Search bioRxiv⌕ Search

Biology subjects

Mahadevan, R.

Publications and source records attributed to Mahadevan, R..

At least 19 recordsLinked to original sources

Do protein representations encode variant function? Diagnosing residue-level protein attributions via embedding-space gradients

A common workflow in protein engineering involves building fitness predictors on protein language models (pLMs) to estimate a variant's fitness and interpret which residues drive it. Attribution methods such as integrated gradients address this second goal by assigning residues contributions to the variant's predicted fitness. However, without ground truth for residue importance, it is unclear whether these attributions reflect what the predictor learned about function. Here, we introduce IGLOO, a framework that scores residue-level attributions against synthetic fitness landscapes with known per-residue importance. Across experimental axes, high predictive accuracy did not guarantee faithful attributions. We identify model interventions that more than double attribution skill scores and raise TOPSIS by 29%, with similar patterns holding in real -amylase and {beta}-lactamase datasets. IGLOO provides a protocol for probing what pLMs learn and a guide for choosing defaults when using residue attributions to pick sequence edits and build more trustworthy protein models.

bioengineering↗

Protective effects of a novel RIPK3 antagonist against neutrophil necroptosis and formation of neutrophil extracellular traps

Functionally competent, highly purified neutrophils were isolated from healthy human donors. Neutrophil necroptosis and neutrophil extracellular trap (NET) formation were induced using TNF- in combination with the pan-caspase inhibitor zVAD-FMK and the IAP antagonist BV6. NETs were visualized, quantified, and morphologically characterized by fluorescence microscopy following staining with Hoechst 33342 and Sytox Green. Levels of extracellular, cell-free neutrophil elastase (NE), myeloperoxidase (MPO), and DNA were also measured as indicators of NET release. The ability of TACT507, a proprietary RIPK3 antagonist, to efficiently block NETs formation and NET related necroptosis was evaluated. TACT507 demonstrated concentration dependent, significant inhibition of neutrophil necroptosis and NETs formation. Summary SentenceIsolated human neutrophils treated ex vivo by TNF- in combination with apoptosis inhibitors, underwent necroptosis causing formation of neutrophil extracellular traps. This process was inhibited by the proprietary antagonist of RIPK3.

cell biology↗

Generalist method to reconstruct metabolic networks from multi-omics data at large-scale

Metabolic network databases often suffer from inconsistent pathways with blocked reactions. Furthermore, current reconstruction methods lack scalable ways to integrate multi-omics data and cannot flexibly combine diverse modeling pipelines. We introduce SPECTRA, a unified platform that reconstructs metabolic networks across multiple biological scales. SPECTRA uses distinct optimization formulations and achieves a 56-fold speed improvement over existing algorithms for flux consistency based model reconstruction. We demonstrated SPECTRA across three applications. First, we extracted models for 1,479 cancer cell lines, capturing more cancer hallmark reactions than current methods. Second, we gap-filled 7,302 microbial reconstructions from the AGORA2 database, reducing blocked reactions from an average of 482 to 169 per model. Third, we modeled synthetic gut microbiota at the community scale with superior performance in reaction inclusion. This framework provides a scalable and flexible approach for modeling metabolic networks, and generates testable hypotheses for machine learning applications in biology.

systems biology↗

kinGEMs: A Robust and Scalable Framework forResource-Constraint Models through StochasticTuning of Deep Learning-Predicted KineticParameters

The construction of accurate enzyme-constrained genome-scale models (ecGEMs) remains a critical challenge in systems biology, limited by sparse kinetic data and the need for biologically meaningful representations. This work presents an integrated framework combining CPI-Pred, a deep learning model to predict kinetic parameters (kcat) from sequence and compound embeddings, with kinGEMs, a pipeline to incorporate these uncertainty-aware parameters into ecGEMs for metabolic optimization. By leveraging representations at multiple scales, the approach captures sequence, structure, and kinetic data to enhance model generalizability and accuracy. Rigorous benchmarking demonstrates the frameworks capability to predict growth rates and fluxes that are consistent with experimental observations and measured proteome fractions, reduce median flux variability by several folds, and yield better-constrained metabolic models by explicitly accounting for the uncertainty inherent in ML-predicted kinetic parameters. kinGEMs successfully generated ecGEMs for 93 models spanning a phylogenetically diverse set of organisms including Gram-negative and Grampositive bacteria, mycobacteria, parasitic protists, fungi, and mammalian cell lines. These innovations breakdown the barrier to application of ecGEMs to non-model organisms and open new avenues for metabolic engineering and synthetic biology in more industrially relevant hosts.

bioengineering↗

Pharmacokinetics and Physiologically Based Pharmacokinetic Modeling of Mycobacteriophages: Insights into Pulmonary Distribution and Clearance

Bacteriophage therapy is being explored as an alternate therapeutic approach for treating drug- resistant bacteria, including mycobacteria. However, rational phage dosing remains limited by scarce pharmacokinetic (PK) data and an incomplete understanding of tissue distribution. We performed dose-ranging studies in mice of three therapeutic mycobacteriophages (BPs{Delta}, ZoeJ{Delta}, Muddy) after intravenous (IV) and intratracheal (IT) administration. All phages behaved similarly. IV dosing produced biphasic kinetics with non-proportional exposure and declining tissue-to-plasma ratios, indicating saturable uptake and elimination. IT delivery yielded monophasic profiles with [~]390-fold higher lung exposure and [~]490-fold lower plasma exposure, supporting inhaled therapy for pulmonary mycobacterial infections. Using BPs{Delta} data, we developed a mechanistic PBPK model incorporating transcytosis, saturable host clearance, plasma elimination, and lymphatic transport. The model accurately predicted ZoeJ{Delta} and Muddy PK, enabled cross-species extrapolation, and showed that phage morphology influences disposition. This framework advances phage therapy toward model-informed, exposure-guided dose and route selection for multidrug-resistant bacterial infections.

pharmacology and toxicology↗

Enabling Plasmid-based Expression in Clostridium kluyveri using a Biparental Methylation-Conjugation System

Clostridium kluyveri is a promising biocatalyst for producing medium-chain fatty acids (MCFAs) from waste-derived carbon via chain elongation. MCFAs are platform chemicals with diverse applications across agriculture, food, cosmetics, and fuels, and could support efforts towards tandem resource recovery and sustainable chemical production. However, genetic intractability has hindered efforts to engineer C. kluyveri for improved product yields, control over chain length and selectivity, and production of non-native oleochemicals. Here, we report a streamlined, biparental methylation-conjugation system developed for C. kluyveri DSM555T to bypass the organisms restriction-modification barriers and enable stable plasmid delivery. We use this system to demonstrate heterologous expression of the Fluorescence-Activated absorption-Shifting Tag (FAST), an anaerobic fluorescent reporter. This system supports advances in metabolic engineering of C. kluyveri and the broader adoption of genetic tools in chain elongating bacteria to expand the applications of anaerobic chain elongation in industrial biomanufacturing. Lay SummaryWe developed a streamlined method for genetically modifying Clostridium kluyveri, a promising strain for industrial anaerobic biomanufacturing, and used it to express a fluorescent protein useful for downstream applications. Graphical Abstract O_FIG O_LINKSMALLFIG WIDTH=200 HEIGHT=120 SRC="FIGDIR/small/657078v2_ufig1.gif" ALT="Figure 1"> View larger version (48K): org.highwire.dtl.DTLVardef@11e2a58org.highwire.dtl.DTLVardef@16e1099org.highwire.dtl.DTLVardef@103c72forg.highwire.dtl.DTLVardef@10a1fce_HPS_FORMAT_FIGEXP M_FIG C_FIG

bioengineering↗

A Mechanism Based Pharmacokinetic/Pharmacodynamic Analysis of Polymyxin B-Based Combination Therapy Against Carbapenem-Resistant Klebsiella pneumoniae Isolates with Diverse Phenotypic and Genotypic Resistance Mechanisms

Increased resistance to {beta}-lactams/{beta}-lactamase inhibitor by mutations in {beta}-lactamases gene, porin mutations and efflux pumps complicates the management of carbapenem-resistant Klebsiella pneumoniae (CRKP). Polymyxin B (PMB) based combination therapy is considered as a best alternative treatment for those middle and low-income countries that cannot access to the latest medicines. Its crucial to know both phenotypic and genotypic characteristics of a pathogen to understand the killing effect of each drug and its combinations. Hence, our objective of this study was to incorporate mechanistic insights gained from resistance mechanisms to develop a mechanism based pharmacokinetic/pharmacodynamic model (MBM). Six clinical CRKP isolates were used for static concentration time kill (SCTK) assays to evaluate the rate and extent of killing by monotherapy, double and triple combinations using PMB, meropenem and fosfomycin. A MBM was developed using the SCTK data in S-ADAPT. The MBM estimated lower maximum killing rate constant of PMB (3.61 h-{superscript 1}) in an isolate with non-functional MgrB and high-level phenotypic resistance. Based upon model discrimination and PMBs outer membrane disruption, mechanistic synergy was included in 3 isolates which has porin mutations. Mechanistic synergy of PMB was 83-88% with meropenem and 81-98% with fosfomycin. The PMB concentration required to achieve 50% of synergy was 0.48-0.64 mg/L. Simulations with a lower PMB regimen (1mg/kg q12h) and fosfomycin (8g q8h) showed >73% reduction in area under the bacterial load-versus-time curve for four isolates. The triple combination showed 67.7% reduction in non-carbapenamase producing isolate. This study demonstrates that a low dosing regimen of PMB can produce synergistic effects in combination therapy and might be effective in managing infections caused by CRKP, including PMB resistant isolates. Author summaryAntimicrobial resistance is a major concern in treating infectious diseases. CRKP bacterial isolates are resistant to most of the novel antimicrobial agents. One of the primary resistant mechanisms is restricting the permeability of drugs to the site of action. Polymyxin B, an antimicrobial agent, disrupts the bacterial outer membrane, enhancing the permeability of other drugs. When using combination therapy with polymyxin B, selecting drugs with different mechanisms of action is crucial to enhance synergistic effects and improve treatment efficacy. In our study we chose to evaluate the efficacy of meropenem and fosfomycin in double and triple combination therapies. Mechanism based models (MBMs) are the strongest tool to analyse the time course bacterial load data. Our study provides insights into applying available phenotypic and genotypic information to refine and enhance the accuracy of MBMs. Final model simulations revealed that low exposure of polymyxin B below the nephrotoxic threshold was sufficient to produce synergistic effects when combined with fosfomycin and meropenem. Additionally, we found that polymyxin B combination with fosfomycin was more effective compared to meropenem in treating CRKP.

pharmacology and toxicology↗

Modeling reveals metabolic basis of competition among Dehalobacter strains during tandem CF and DCM metabolism

SC05-UT is an anaerobic mixed microbial enrichment culture that reduces chloroform (CF) to dichloromethane (DCM) through reductive dechlorination, which it further mineralizes to carbon dioxide. This DCM mineralization yields electron equivalents that are used to reduce CF without addition of exogenous electron donor. By studying this self-feeding CF-amended culture and a DCM-amended enrichment culture (DCME), we previously found the genomic potential to perform both biodegradation steps in two distinct Dehalobacter strains: Dehalobacter restrictus SAD and Candidatus Dehalobacter alkaniphilus DAD. Though present in each enrichment culture, strain SAD is more abundant in CF-fed subculture SC05-UT, while strain DAD is more prominent in the DCM-fed subculture DCME. To understand if genomic differences between strains and impact their metabolic mechanisms, the genome of each strain was curated to reconstruct genome-scale metabolic models of each strain, which were then constrained based on thermodynamic and experimental conditions. We demonstrate that metabolic differences between the two strains may allow Dehalobacter strain DAD to outcompete strain SAD in the absence of CF, while strain SAD exhibits an advantage in the presence of CF. Additionally, we predict electron cycling methods to reconcile redox imbalances in the cell is required for tandem CF and DCM dechlorination. This work highlights the importance of hydrogen and amino acid exchange in these microbial communities and contributes to the growing body of work surrounding organohalide syntrophy. ImportanceChloroform and dichloromethane contaminate groundwater around the world but can be remediated by microbes capable of metabolizing these toxic compounds. Here we study two distinct strains of Dehalobacter and show that while both strains can degrade both chloroform and dichloromethane, differences in their genetic makeup allow each strain to thrive under different environmental conditions. This has implications for understanding the fate of halogenated methanes in the environment and the application of Dehalobacter for bioremediation of chlorinated compounds.

microbiology↗

CPI-Pred: A deep learning framework for predicting functional parameters of compound-protein interactions

Recent advancements in deep learning have enabled functional annotation of genome sequences, facilitating the discovery of new enzymes and metabolites. However, accurately predicting compound-protein interactions (CPI) from sequences remains challenging due to the complexity of these interactions and the sparsity and heterogeneity of available data, which constrain the generalization of patterns across their solution space. In this work, we introduce CPI-Pred, a versatile deep learning model designed to predict compound-protein interaction function. CPI-Pred integrates compound representations derived from a novel message-passing neural network and enzyme representations generated by state-of-the-art protein language models, leveraging innovative sequence pooling and cross-attention mechanisms. To train and evaluate CPI-Pred, we compiled the largest dataset of enzyme kinetic parameters to date, encompassing four key metrics: the Michaelis-Menten constant (KM), enzyme turnover number (kcat), catalytic efficiency (kcat/KM), and inhibition constant (KI).These kinetic parameters are critical for elucidating enzyme function in metabolic contexts and understanding their regulation by compounds within biological networks. We demonstrate that CPI-Pred can predict diverse types of CPI using only the amino acid sequence of enzymes and structural representations of compounds, outperforming state-of-the-art models on unseen compounds and structurally dissimilar enzymes. Over workflow provides a valuable tool for tackling a range of metabolic engineering challenges, including the designing of novel enzyme sequences and compounds, such as enzyme inhibitors. Additionally, the datasets curated in this study offer a valuable resource for the scientific community, serving as a benchmark for machine learning models focused on enzyme activity and promiscuity prediction.

bioinformatics↗

Synthetic metabolic pathways for ethylene glycol assimilation outperform natural counterparts

Biomanufacturing can play a pivotal role in the transition away from fossil fuel dependence for the production of chemicals and fuels. There is growing interest in alternative bioproduction feedstocks to conventional sugars that do not compete for land use with food production. Ethylene glycol, a C2 compound that can be recovered from plastic waste or derived from CO2 with increasing efficiency, is gaining attention as a carbon source for microbial processes. Here we review the natural and synthetic metabolic pathways currently available for ethylene glycol assimilation. The pathways are compared in terms of their maximum theoretical yields for biomass and value-added products, thermodynamic favourability, minimum enzyme costs, and orthogonality to central carbon metabolism. We find that synthetic pathways outperform their natural counterparts in terms of higher thermodynamic driving forces, reduced enzyme costs, and higher theoretical yields for the majority of bioproducts analyzed as well as for biomass. However, natural assimilation pathways are equally or even more orthogonal to growth-associated reactions than synthetic pathways. Given these tradeoffs, the optimal EG assimilation pathway may depend on product and process choice.

bioengineering↗

Optimizing Fed-Batch Processes with Dynamic Control Flux Balance Analysis

Fed-batch processes are prevalent in biotechnological industries, but design of experiments often results in sub-optimal conditions due to incomplete solution space characterization. We employ a single-level dynamic control (DC) algorithm for dynamic flux balance analysis (dFBA), enhancing efficiency by reducing Karush-Kuhn-Tucker (KKT) condition constraints and adapting the algorithm for predicting optimal process length. In a growth-decoupled plasmid DNA production case study, we predict the optimal feeding profile and switching time between growth and production phase. Comparing our algorithm to its predecessor shows a speed-up of at least a factor of four. When the process length is part of the objective function the speed-up becomes considerably larger.

bioengineering↗

Evaluating the feasibility of medium chain oleochemical synthesis using microbial chain elongation

Chain elongating bacteria are a unique guild of strictly anaerobic bacteria that have garnered interest for sustainable chemical manufacturing from carbon-rich wet and gaseous waste streams. They produce C6-C8 medium-chain fatty acids which are valuable platform chemicals that can be used directly, or derivatized to service a wide range of chemical industries. However, the application of chain elongating bacteria for synthesizing products beyond C6-C8 medium-chain fatty acids has not been evaluated. In this study, we assess the feasibility of expanding the product spectrum of chain elongating bacteria to C9-C12 fatty acids, along with the synthesis of C6 fatty alcohols, dicarboxylic acids, diols, and methyl ketones. We propose several metabolic engineering strategies to accomplish these conversions in chain elongating bacteria and utilize constraint-based metabolic modelling to predict pathway stoichiometries, assess thermodynamic feasibility, and estimate ATP and product yields. We also evaluate how producing alternative products impacts the growth rate of chain elongating bacteria via resource allocation modelling, revealing a trade-off between product carbon length and class versus cell growth rate. Together, these results highlight the potential for using chain elongating bacteria as a platform for diverse oleochemical biomanufacturing and offer a starting point for guiding future metabolic engineering efforts aimed at expanding their product range. Graphical AbstractIn this work, the authors use constraint-based metabolic modelling and enzyme cost minimization to assess the feasibility of using metabolic engineering to expand the product spectrum of anaerobic chain elongating bacteria. O_FIG O_LINKSMALLFIG WIDTH=200 HEIGHT=98 SRC="FIGDIR/small/592817v1_ufig1.gif" ALT="Figure 1"> View larger version (10K): org.highwire.dtl.DTLVardef@725c90org.highwire.dtl.DTLVardef@1b2575org.highwire.dtl.DTLVardef@382c95org.highwire.dtl.DTLVardef@1f71ea0_HPS_FORMAT_FIGEXP M_FIG C_FIG One Sentence SummaryIn this work, the authors use constraint-based metabolic modelling and enzyme cost minimization to assess the feasibility of using metabolic engineering to expand the product spectrum of anaerobic chain elongating bacteria.

bioengineering↗

Understanding systems level metabolic adaptation resulting from osmotic stress

An organisms survival hinges on maintaining the right thermodynamic conditions. Osmotic constraints limit the concentration range of metabolites, affecting essential cellular pathways. Despite extensive research on osmotic stress and growth, understanding remains limited, especially in hypo-osmotic environments. To delve into this, we developed a novel modeling approach that considers metabolic fluxes and metabolite concentrations along with thermodynamics. Our analysis of E. coli adaptation reveals insights into growth rates, metabolic pathways, and thermodynamic bottlenecks during transitions between hypo- and hyper-osmotic conditions. Both experimental and computational findings show that cells prioritize pathways that have higher thermodynamic driving force, like the pentose phosphate or the Entner-Doudoroff pathway, under low osmolarity. This work offers a systematic and mechanistic explanation for reduced growth rates in hypo- and hyper-osmotic conditions. The developed framework is the first of its kind to incorporate genome wide constraints that consider both natural logarithm and actual metabolite concentrations. O_FIG O_LINKSMALLFIG WIDTH=200 HEIGHT=112 SRC="FIGDIR/small/585265v2_ufig1.gif" ALT="Figure 1"> View larger version (19K): org.highwire.dtl.DTLVardef@193001dorg.highwire.dtl.DTLVardef@1ec76e1org.highwire.dtl.DTLVardef@170c554org.highwire.dtl.DTLVardef@ab4f29_HPS_FORMAT_FIGEXP M_FIG C_FIG

microbiology↗

Identification of functional genes in a chloroform and dichloromethane-degrading microbial culture

Chloroform (CF) and dichloromethane (DCM) are groundwater contaminants of concern due to their high toxicity and inhibition of important biogeochemical processes such as methanogenesis. Anaerobic biotransformation of CF and DCM has been well documented but typically independently of one another. CF is the electron acceptor for certain organohalide-respiring bacteria that use reductive dehalogenases (RDases) to dechlorinate CF to DCM. In contrast, known DCM-degraders use DCM as their electron donor, which is oxidized using a series of methyltransferases and associated proteins encoded by the mec cassette to facilitate the entry of DCM to the Wood-Ljungdahl pathway. The SC05 culture is an enrichment culture sold commercially for bioaugmentation, that transforms CF via DCM to CO2. This culture has the unique ability to dechlorinate CF to DCM using electron equivalents provided by the oxidation of DCM to CO2. Here we use metagenomic and metaproteomic analysis to identify the functional genes involved in each of these transformations. Though 91 metagenome-assembled genomes were assembled, the genes for an RDase--named acdA--and a complete mec cassette were found to be encoded on a single contig belonging to Dehalobacter. AcdA and critical Mec proteins were also highly expressed by the culture. Heterologously-expressed AcdA dechlorinated CF and other chloroalkanes but had 100-fold lower activity on DCM. Overall, the high expression of Mec proteins and the activity of AcdA suggest a Dehalobacter capable of dechlorination of CF to DCM, and subsequent mineralization of DCM using the mec cassette. ImportanceChloroform (CF) and dichloromethane (DCM) are regulated groundwater contaminants. A cost-effective approach to remove these pollutants from contaminated groundwater is to employ microbes that transform CF and DCM as part of their metabolism, thus depleting the contamination as the microbes continue to grow. In this work, we investigate bioaugmentation culture SC05, a mixed microbial consortium that effectively and simultaneously degrades both CF and DCM coupled to the growth of Dehalobacter. We identified the functional genes responsible for the transformation of CF and DCM in SC05. These genetic biomarkers provide a means to monitor the remediation process in the field.

microbiology↗

A multifunctional Dehalobacter? Tandem chloroform and dichloromethane degradation in a mixed microbial culture

Chloroform (CF) and dichloromethane (DCM) contaminate groundwater sites around the world, which can be remediated through bioaugmentation. Although several strains of Dehalobacter restrictus can reduce CF to DCM, and multiple Peptococcaceae can ferment DCM, these processes cannot happen simultaneously due to CF sensitivity in the known DCM-degraders or electron donor competition. Here we present a mixed microbial culture that can simultaneously metabolize CF and DCM to carbon dioxide and create an additional enrichment culture fed only DCM. Through species-specific qPCR, we find that a Dehalobacter strain grows both while CF alone and DCM alone are converted, indicating its involvement in both metabolic steps. Additionally, the culture was maintained for over 1400 days without addition of exogenous electron donor, and through electron balance calculations we show that DCM mineralization produces sufficient reducing equivalents (likely hydrogen) for CF respiration. Together, these results suggest intraspecies electron transfer could occur to continually reduce CF in the culture. Minimizing the addition of electron donor reduces the cost of bioremediation, and understanding this mechanism informs strategies for culture maintenance and scale-up, and benefits contaminated sites where the culture is employed for remediation worldwide. SYNOPSISDechlorination of chloroform to dichloromethane and dichloromethane mineralization are performed concurrently by a Dehalobacter-containing mixed microbial community without provision of exogenous electron donor. TOC ART O_FIG O_LINKSMALLFIG WIDTH=200 HEIGHT=104 SRC="FIGDIR/small/552028v1_ufig1.gif" ALT="Figure 1"> View larger version (29K): org.highwire.dtl.DTLVardef@8e3002org.highwire.dtl.DTLVardef@f1d396org.highwire.dtl.DTLVardef@7a59dborg.highwire.dtl.DTLVardef@a179bc_HPS_FORMAT_FIGEXP M_FIG C_FIG

microbiology↗

Functional and Structural Characterization of an IclR Family Transcription Factor for the Development of Dicarboxylic Acid Biosensors

Prokaryotic transcription factors (TFs) regulate gene expression in response to small molecules, thus representing promising candidates as versatile small molecule-detecting biosensors valuable for synthetic biology applications. The engineering of such biosensors requires thorough in vitro and in vivo characterization of TF ligand response as well as detailed molecular structure information. In this work we characterize the PcaR TF belonging to the IclR family. We present in vitro functional analysis of PcaRs ligand profile and construction of genetic circuits for the characterization of PcaR as an in vivo biosensor in the model eukaryote Saccharomyces cerevisiae. We report the crystal structures of PcaR in the apo state and in complex with one of its ligands, succinate, which suggests the mechanism of dicarboxylic acid recognition by this TF. This work provides key structural and functional insights enabling the engineering of PcaR for dicarboxylic acid biosensors. Graphical Abstract O_FIG O_LINKSMALLFIG WIDTH=200 HEIGHT=50 SRC="FIGDIR/small/550818v1_ufig1.gif" ALT="Figure 1"> View larger version (15K): org.highwire.dtl.DTLVardef@16bcdd2org.highwire.dtl.DTLVardef@95ba9forg.highwire.dtl.DTLVardef@f598borg.highwire.dtl.DTLVardef@1bfe5f2_HPS_FORMAT_FIGEXP M_FIG C_FIG HighlightsO_LIPcaR is an IclR family transcription regulator responsive to dicarboxylic acids C_LIO_LIPcaR was established as an in vivo biosensor in yeast C_LIO_LICrystal structure of PcaR in the apo form was solved C_LIO_LICrystal structure with PcaR in complex with succinate was solved C_LIO_LISequence alignments unveil ligand-binding positions in the IclR family C_LI

synthetic biology↗

standard-GEM: standardization of open-source genome-scale metabolic models

The field of metabolic modelling at the genomescale continues to grow with more models being created and curated. This comes with an increasing demand for adopting common principles regarding transparency and versioning, in addition to standardisation efforts regarding file formats, annotation and testing. Here, we present a standardised template for git-based and GitHub-hosted genome-scale metabolic models (GEMs) supporting both new models and curated ones, following FAIR principles (findability, accessibility, interoperability, and reusability), and incorporating bestpractices. standard-GEM facilitates the reuse of GEMs across web services and platforms in the metabolic modelling field and enables automatic validation of GEMs. The use of this template for new models, and its adoption for existing ones, paves the way for increasing model quality, openness, and accessibility with minimal effort. Availabilitystandard-GEM is available from github.com/MetabolicAtlas/standard-GEM under the conditions of the CC BY 4.0 licence along with additional supporting material.

systems biology↗

Engineering Escherichia coli to produce aromatic chemicals from ethylene glycol

Microbial overproduction of aromatic chemicals has gained considerable industrial interest and various metabolic engineering approaches have been employed in recent years to address the associated challenges. So far, most studies have used sugars (mostly glucose) or glycerol as the primary carbon source. In this study, we used ethylene glycol (EG) as the main carbon substrate. EG could be obtained from the degradation of plastic and cellulosic wastes. As a proof of concept, Escherichia coli was engineered to transform EG into L-tyrosine, a valuable aromatic amino acid. Under the best fermentation condition, the strain produced 2 g/L L-tyrosine from 10 g/L EG at approximately 50% of the theoretical yield, outperforming glucose (the most common sugar feedstock) in the same experimental conditions. To prove the concept that EG can be converted into different aromatic chemicals, E. coli was further engineered with a similar approach to synthesize other valuable aromatic chemicals, L-phenylalanine and p-coumaric acid. Finally, waste polyethylene terephthalate (PET) bottles were degraded using acid hydrolysis and the resulting monomer EG was transformed into L-tyrosine using the engineered E. coli, yielding a comparable titer to that obtained using commercial EG. The strains developed in this study should be valuable to the community for producing valuable aromatics from EG.

bioengineering↗